Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to provide information on maternal, fetal, and infant outcomes following exposure of ozanimod during pregnancy so that participants and physicians can weigh the benefits and risks of exposure to the pharmaceutical during pregnancy and make informed treatment decisions.
Official title: ZEPOSIA® (Ozanimod) Pregnancy Registry: A Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1182
Start Date
2022-07-15
Completion Date
2032-06-30
Last Updated
2025-11-20
Healthy Volunteers
Not specified
Conditions
Locations (3)
Evidera INC.
Bethesda, Maryland, United States
Evidera
Bethesda, Maryland, United States
Marienhospital Herne, Klinikum Der Ruhr-Universitaet Bochum
Herne, Germany